Yasmim Gabriele Matos

1PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Apr 26, 2025
Association of ABC Efflux Transporter Genetic Variants and Adverse Drug Reactions and Survival in Patients with Non-Small Lung Cancer.

Cecilia Souto Seguin, Giovana Fernanda Santos Fidelis, Carolina Dagli-Hernandez

Pageof 1

Frequent Collaborators

1 joint publications

Giovana Fernanda Santos Fidelis

1 joint publications

Carolina Dagli-Hernandez

1 joint publications

Pedro Eduardo Nascimento Silva Vasconcelos

1 joint publications

Mariana Vieira Morau

1 joint publications

Maurício Wesley Perroud

1 joint publications

Patricia Moriel

Frequent Collaborators

1 joint publications

Giovana Fernanda Santos Fidelis

1 joint publications

Carolina Dagli-Hernandez

1 joint publications

Pedro Eduardo Nascimento Silva Vasconcelos

1 joint publications

Mariana Vieira Morau

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

7.8K
See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

7.8K
See more related videos